Pharmala Biotech Holdings Inc. (CSE:MDMA)
0.1400
-0.0100 (-6.67%)
Nov 20, 2026, 3:55 PM EST
Pharmala Biotech Holdings Market Cap
Pharmala Biotech Holdings has a market cap or net worth of CAD 15.36 million as of November 20, 2026. It is the 40,640th most valuable company in the world and the 1,320th biggest in Canada. Its market cap has increased by 28.52% in one year.
Market Cap
15.36M
Enterprise Value
15.11M
Revenue
1.27M
Global Rank
Country Rank
#1,320 Canada
PE Ratio
n/a
ChartMarket Cap Chart
Since January 11, 2022, Pharmala Biotech Holdings's market cap has increased from 6.64M to 15.36M, an increase of 131.26%. That is a compound annual growth rate of 18.83%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2026 | 15.36M | 28.20% |
| Dec 31, 2025 | 11.98M | -53.64% |
| Dec 31, 2024 | 25.84M | 112.35% |
| Dec 29, 2023 | 12.17M | 486.37% |
| Dec 30, 2022 | 2.07M | -68.75% |
| Jan 11, 2022 | 6.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Telescope Innovations | 22.63M |
| Medicenna Therapeutics | 21.23M |
| The More Life Company | 20.57M |
| Defence Therapeutics | 19.79M |
| Devonian Health Group | 17.52M |
| Lobe Sciences | 16.98M |
| Rapid Dose Therapeutics | 13.09M |
| Alzai Health | 12.96M |